Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Universiti Brunei Darussalam currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are being handled by 1 distinct examiner within 1 distinct art unit. This indicates that all of the university's current pending matters are being reviewed by the same person in the same administrative group. The concentration of all activity in 1 distinct art unit suggests a very specific technical focus for the university's current biotechnology applications.
HAQ, SHAFIQUL is the busiest examiner for the portfolio, managing 2 pending office actions. This examiner is responsible for the entirety of the university's pending office actions. Because there is only 1 distinct examiner involved, the university's prosecution strategy is highly centralized. This singular point of contact for the 2 pending office actions means that the outcomes for both matters are determined by the same examiner's interpretation and the same art unit's standards.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAQ, SHAFIQUL | 2 | 64.8% | +55.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18583498 | Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin | HAQ, SHAFIQUL | — |
| 18583424 | Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin | HAQ, SHAFIQUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18583498 | Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin | HAQ, SHAFIQUL | — |
| 18583424 | Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin | HAQ, SHAFIQUL | — |
| Art Unit | Apps |
|---|---|
| 1678 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18583498 | Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin | HAQ, SHAFIQUL | 1678 | §102§103§112 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18583424 | Carbon Nanohorns/Nafion/Fe3O4@Pd immunosensor for Shrimp Tropomyosin | HAQ, SHAFIQUL | 1678 | §102§103 | Non-Final OA | — | Pending | Feb 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversiti Brunei Darussalam has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Shafiqul Haq has the most, with 2 of Universiti Brunei Darussalam's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
